explore -WSS

explore

author：Wikipedia 2025-09-06 02:16:48 - browse：5

Are venture capitalists OK? Are bolt-ons good for business? And when is it safe to say someone overpaid?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how biotech’s downturn has made life difficult not just for startups but also the VCs they rely on for much-needed funding. We also take a look at Gilead Sciences’ struggle to turn itself into an oncology company and the latest biotech to get bought out by a major pharma firm.

For more on what we cover, here’s more on Gilead; here’s the news on Inhibrx; here’s the latest on biotech venture capital; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： {$word} {$title}

WSS

Microsoft strikes partnership with Duke Health to advance health AI

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

ProMED, early warning system on disease outbreaks, in peril

TytoCare raises $49 million to build out AI

Bristol 'take

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Wikipedia

explore

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The future of health care in the House

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The drug industry sees a key ally in the Senate prevail

Wildfire smoke exposes gaps in outdoor worker protections

Why Charlie Gard's case is so disturbing to Americans

Trump demands the U.S. pay no more for drugs than other countries … again

TytoCare raises $49 million to build out AI

Wildfire smoke exposes gaps in outdoor worker protections

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

hotspot

Attacks on the drug industry will lead to fewer breakthroughs

Microsoft strikes partnership with Duke Health to advance health AI

FDA rejects Alnylam's heart disease treatment over insufficient data

For BCIs, commercial hurdles may be bigger than scientific ones

Bill would stop addiction treatment from triggering child abuse inquiry

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

leisure time

explore

hotspot

focus